Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial

著者: Seung‐Jung Park, Jung‐Min Ahn, Do‐Yoon Kang, Sung‐Cheol Yun, Youngkeun Ahn, Won‐Jang Kim, Chang‐Wook Nam, Jin‐Ok Jeong, In‐Ho Chae, Hiroki Shiomi, Hsien‐Li Kao, Joo‐Yong Hahn, Sung‐Ho Her, Bong‐Ki Lee, Tae Hoon Ahn, Kiyuk Chang, Jei Keon Chae, David Smyth, Gary S. Mintz, Gregg W. Stone, Duk‐Woo Park, Seung‐Jung Park, Jung‐Min Ahn, Do‐Yoon Kang, Sung‐Cheol Yun, Youngkeun Ahn, Won‐Jang Kim, Chang-Wook Nam Nam, Jin‐Ok Jeong, In‐Ho Chae, Hiroki Shiomi, Hsien‐Li Kao, Joo‐Yong Hahn, Sung‐Ho Her, Bong‐Ki Lee, Tae Hoon Ahn, Kiyuk Chang, Jei-Keon Chae, David Smyth, Gary S. Mintz, Gregg W. Stone, Duk‐Woo Park, Gary S. Mintz, Gregg W. Stone, Duk‐Woo Park, Duk‐Woo Park - The Lancet 2024 被引用: 244